STING and TLR7/8 agonists-based nanovaccines for synergistic antitumor immune activation

Immunostimulatory therapies based on pattern recognition receptors (PRRs) have emerged as an effective approach in the fight against cancer, with the ability to recruit tumor-specific lymphocytes in a low-immunogenicity tumor environment. The agonist cyclic dinucleotides (CDNs) of the stimulator of...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Bo-Dou, Wu, Jun-Jun, Li, Wen-Hao, Hu, Hong-Guo, Zhao, Lang, He, Pei-Yang, Zhao, Yu-Fen, Li, Yan-Mei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tsinghua University Press 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9014842/
https://www.ncbi.nlm.nih.gov/pubmed/35464625
http://dx.doi.org/10.1007/s12274-022-4282-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9014842/
https://www.ncbi.nlm.nih.gov/pubmed/35464625
http://dx.doi.org/10.1007/s12274-022-4282-x

Ejemplares similares